Transfusion‐dependent thalassaemic patients with renal Fanconi syndrome due to deferasirox use

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|12|931-935

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.12, 2015-12, pp. : 931-935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deferasirox effect on renal haemodynamic parameters in patients with transfusion‐dependent β thalassaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 882-890

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life measurement in patients with transfusion‐dependent myelodysplastic syndromes

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 121, Iss. 2, 2003-04 ,pp. : 270-274

John Wiley & Sons Inc

Access to resources Recommend Favorite

Deferasirox Treatment Improved the Hemoglobin Level and Decreased Transfusion Requirements in Four Patients with the Myelodysplastic Syndrome and Primary Myelofibrosis

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 70-74

Karger

Access to resources Recommend Favorite

Deferasirox in thalassemia patients with end‐stage renal disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 91, Iss. 10, 2016-10 ,pp. : E456-E457

John Wiley & Sons Inc

Access to resources Recommend Favorite

Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion‐dependent β‐thalassaemia major patients

By  

VOX SANGUINIS, Vol. 108, Iss. 3, 2015-04 ,pp. : 268-273

John Wiley & Sons Inc

Access to resources Recommend Favorite